Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology

Gabor Valcz, Ferenc Sipos, Zsolt Tulassay, Bela Molnar, Yukako Yagi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Carcinoma-associated fibroblast (CAF) as prominent cell type of the tumour microenvironment has complex interaction with both the cancer cells and other nonneoplastic surrounding cells. The CAF-derived regulators and extracellular matrix proteins can support cancer progression by providing a protective microenvironment for the cancer cells via reduction of chemotherapy sensitivity. On the other hand, these proteins may act as powerful prognostic markers as well as potential targets of anticancer therapy. In this review, we summarise the clinical importance of the major CAF-derived signals influencing tumour behaviour and determining the outcome of chemotherapy.

Original languageEnglish
Pages (from-to)1026-1031
Number of pages6
JournalPostgraduate Medical Journal
Volume91
Issue number1075
DOIs
Publication statusPublished - Jan 1 2015

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology'. Together they form a unique fingerprint.

  • Cite this